Hypermarcas (OTCMKTS:HYPMY) Shares Down 4.3% - Should You Sell?

Key Points

• Hypermarcas's stock price decreased by 4.3% to $4.40, with trading volume significantly down at 1,782 shares compared to the average of 68,639 shares.
• Wall Street analysts maintain a strong-buy rating for Hypermarcas, indicating positive sentiment towards the stock despite its recent price drop.
• The company announced a dividend of $0.0345 per share, reflecting a yield of 281.0%, with the payment scheduled for January 8th.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report)'s stock price traded down 4.3% during mid-day trading on Wednesday . The stock traded as low as $4.30 and last traded at $4.40. 1,782 shares traded hands during trading, a decline of 97% from the average session volume of 68,639 shares. The stock had previously closed at $4.60.

Wall Street Analysts Forecast Growth

Separately, Scotiabank upgraded Hypermarcas to a "strong-buy" rating in a report on Thursday, July 17th. One analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, the stock has a consensus rating of "Strong Buy".

Hypermarcas Stock Performance

The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.80 and a current ratio of 1.26. The stock has a fifty day simple moving average of $4.45 and a two-hundred day simple moving average of $4.19. The stock has a market capitalization of $2.87 billion, a price-to-earnings ratio of 21.55 and a beta of 0.86.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported $0.12 earnings per share (EPS) for the quarter. Hypermarcas had a net margin of 11.28% and a return on equity of 6.19%.

Hypermarcas Dividend Announcement

The business also recently disclosed a dividend, which will be paid on Friday, January 8th. Stockholders of record on Tuesday, July 1st will be given a dividend of $0.0345 per share. This represents a dividend yield of 281.0%. The ex-dividend date of this dividend is Monday, June 30th. Hypermarcas's dividend payout ratio is 57.14%.

About Hypermarcas

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.